Referrals for positive tuberculin tests in new health care workers and students: A retrospective cohort study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Xu, Yining ^a,b   Schwartzman, Kevin ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADULT; ARTICLE; CANADA; COHORT ANALYSIS; ETHNOLOGY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MALE; MIGRATION; PATIENT REFERRAL; RETROSPECTIVE STUDY; STATISTICS; STUDENT; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; BCG VACCINE; COHORT STUDIES; EMIGRANTS AND IMMIGRANTS; FEMALE; FOLLOW-UP STUDIES; HEALTH PERSONNEL; HUMANS; MALE; QUEBEC; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; STUDENTS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 77449146781     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-28     Document Type: Article

References (35)

1. Global tuberculosis control: epidemiology, strategy, financing. World Health Organization, WHO Report 2009. WHO/HTM/TB/2008.411 Geneva, Switzerland: WHO Press http://www.who.int/tb/publications/global-report/2009/pdf/full-report. pdf on October 20, 2009
2. Global epidemiology of tuberculosis. C Dye, Lancet 2006 367 938 940 10.1016/S0140-6736(06)68384-0 16546542
3. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. R Joshi AL Reingold D Menzies M Pai, PLoS Medicine 2006 3 494 10.1371/journal.pmed.0030494 17194191
4. Tuberculosis among health care workers. D Menzies A Fanning L Yuan M Fitzgerald, N Engl J Med 1995 332 92 98 10.1056/NEJM199501123320206 7990907
5. Public Health Agency of Canada, Tuberculosis in Canada 2007-Pre-release Ottawa, Canada: Minister of Public Works and Government Services Canada 2008 http://www.phac-aspc.gc.ca/publicat/2008/tbcanpre07/pdf/tbpre2007-eng.pdf
6. Tuberculosis infection among health care workers in Montreal. K Schwartzman V Loo J Pasztor D Menzies, Am J Respir Crit Care Med 1996 154 1006 1012 8887599
7. Hospital ventilation and risk for tuberculous infection in Canadian health care workers. D Menzies A Fanning L Yuan JM FitzGerald, Ann Intern Med 2000 133 779 789 11085840
8. Tuberculosis outbreak among health care workers in a community hospital. DE Griffith JL Hardman Y Zhang RJ Wallace GH Mazurek, Am J Respir Crit Care Med 1995 152 808 811 7633747
9. Transmission of Mycobacterium tuberculosis from health care workers. TR Sterling DW Haas, N Engl J Med 2006 355 118 121 10.1056/NEJMp068015 16837674
10. Centers for Disease Control and Prevention, Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005 CDC MMWR 2005 54 No. RR-17 1 140
11. R Long ed, Canadian tuberculosis standards Ottawa, Canada: Health Canada 6 2007 http://www.phac-aspc.gc.ca/tbpc-latb/pubs/pdf/tbstand07-e.pdf Accessed on-line October 14, 2009
12. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society/Centers for Disease Control and Prevention, Am J Respir Crit Care Med 2000 161 5221 5247
13. American Thoracic Society/Centers for Disease Control and Prevention, Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and Revisions in American Thoracic Society/CDC Recommendations - United States, 2001 CDC MMWR 2001 50 34 733 735
14. Adverse events with 4 months rifampin or 9 months isoniazid as therapy for latent TB infection: results of a randomized trial. D Menzies R Long A Trajman MJ Dion J Yang H Al Jahdali Z Memish K Khan M Gardam V Hoeppner A Benedetti K Schwartzman, Ann Intern Med 2008 149 689 697 19017587
15. Tuberculosis in health care workers: a multicentre Canadian prevalence survey: preliminary results. D Menzies A Fanning L Yuan J Mark FitzGerald Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis, Int J Tuberc Lung Dis 1998 2 98 S102 9755973
16. Effect of Bacille Calmette-Guerin vaccination on tuberculin reactivity. R Menzies B Vissandjee, Am Rev Respir Dis 1992 145 621 645 1546843
17. Interpretation of repeated tuberculin tests: Boosting, conversion and reversion. D Menzies, Am J Respir Crit Care Med 1999 159 15 21 9872812
18. Factors associated with the treatment of latent tuberculosis infection among health-care workers at a Midwestern teaching hospital. SJ Shukla DK Warren KF Woeltje CA Gruber VJ Fraser, Chest 2002 122 1609 1614 10.1378/chest.122.5. 1609 12426260
19. Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis. SR Salpeter EE Salpeter, Infect Control Hosp Epidemiol 2004 25 1056 1061 10.1086/502343 15636292
20. Health care workers and the initiation of treatment for latent tuberculosis infection. AS Gershon A McGeer AM Bayoumi J Raboud J Yang, Clin Infect Dis 2004 39 667 672 10.1086/422995 15356781
21. Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments. L Lambert S Rajbhandary N Quails L Budnick A Catanzaro S Cook L Daniels-Cuevas E Garber R Reves, Infect Control Hosp Epidemiol 2003 24 814 820 10.1086/502142 14649768
22. Acceptance of isoniazid preventive therapy by health care workers after tuberculin skin test conversion. BC Camins N Bock DL Watkins HM Blumberg, JAMA 1996 275 1013 1015 10.1001/jama.275.13.1013 8596233
23. Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital. PA LoBue A Catanzaro, Chest 1998 113 1184 1189 10.1378/chest.113.5.1184 9596292
24. Screening of physicians for tuberculosis. VJ Fraser CM Kilo TC Bailey G Medoff WC Dunagan, Infect Control Hosp Epidemiol 1994 15 95 100 10.1086/646868 8201241
25. Committee on the elimination of tuberculosis in the United States, Division of health promotion and disease prevention, Institute of Medicine, Ending neglect: the elimination of tuberculosis in the United States Washington: National Academy Press 2000
26. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. K Dasgupta K Schwartzman R Marchand TN Tannenbaum P Brassard D Menzies, Am J Respir Crit Care Med 2001 162 2079 2086
27. Interferon-gamma release assays and TB screening in high-income countries: A cost-effectiveness analysis. O Oxlade K Schwartzman D Menzies, Int J Tuberc Lung Dis 2007 11 16 26 17217125
28. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. K Schwartzman D Menzies, Am J Respir Crit Care Med 2000 161 780 789 10712322
29. Does the implementation of an Interferon- release assay in lieu of a tuberculin skin test increase acceptance of preventive therapy for latent tuberculosis among healthcare workers? R Sahni C Miranda B Yen-Lieberman JW Tomford P Terpeluk P Quartey LT Johnson SM Gordon, Infect Control Hosp Epidemiol 2009 30 197 199 10.1086/593965 19119939
30. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. R Diel P Wrighton-Smith J-P Zellweger, Eur Respir J 2007 30 321 332 10.1183/09031936.00145906 17504793 (Pubitemid 47194185)
31. Canadian Tuberculosis Committee, Public Health Agency of Canada, An Advisory Committee Statement: Updated recommendations on interferon-gamma release assays for latent tuberculosis infection. Canada Communicable Disease Report 2008 34 CS-6 http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/08pdf/acs-6. pdf
32. Clinical Guideline 33. National Health Service National Institute for Health and Clinical Excellence, Tuberculosis: clinical diagnosis and management of tuberculosis, and guidelines for its prevention and control 2006 http://www.nice.org.uk/nicemedia/pdf/CG033niceguideline.pdf Accessed October 20, 2009
33. Prognostic value of a T-cell based, interferon-gamma biomarker in children with tuberculosis contact. M Bakir KA Millington A Soysal JJ Deeks S Efee Y Aslan DPS Dosanjh A Lalvani, Ann Intern Med 2008 149 777 786 18936496
34. Within-subject variability and boosting of T-cell Interferon- y responses after tuberculin skin testing. RN van Zyl-Smit M Pai K Peprah R Meldau J Kieck J Juritz M Badri A Zumla LA Sechi ED Bateman K Dheda, Am J Respir Crit Care Med 2009 180 49 58 10.1164/rccm.200811-1704OC 19342414
35. Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. D Menzies M Pai G Comstock, Ann Intern Med 2007 146 340 354 17339619